Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2019;8(3): 204-210. doi:
10.15171/jrip.2019.38
Original
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis
Mohammadreza Nakhjavani
1
, Sima Abediazar
2
, Amir Ghorbanihaghjo
3
*
, Niloofar Esmaeili
1
, Tala Pourlak
2
, Sepideh Zununi Vahed
2
Cited by CrossRef: 3
1- Paquissi F, Abensur H. The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis.
Front Med
. 2021;8
[Crossref]
2- Yin R, Xu R, Ding L, Sui W, Niu M, Wang M, Xu L, Wang H, Srirat C, Nozawa K. Circulating IL‐17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta‐Analysis.
BioMed Research International
. 2021;2021(1)
[Crossref]
3- Richter P, Macovei L, Mihai I, Cardoneanu A, Burlui M, Rezus E. Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17.
IJMS
. 2023;24(19):14413
[Crossref]